About this Event
Phase 1 of MOHCCN focused on building the infrastructure for collaborative cancer research across Canada, establishing a national data-sharing network and supporting the genomic sequencing of primarily retrospective patient cohorts.
Now, Phase 2 marks an exciting shift from research infrastructure to clinical implementation. Building on the foundation established in Phase 1, this next phase aims to bring precision oncology programs, like BC Cancer’s Personalized OncoGenomics (POG) program, to clinical settings across Canada. The goal is to translate genomic discoveries into meaningful insights that can inform patient care and, ultimately, help make precision oncology a standard part of cancer treatment.
In British Columbia, Phase 2 brings together a number of research and clinical cohorts, largely building on the work of POG, alongside nine special projects designed to address key challenges and support the implementation of precision oncology in clinical practice.
Join us to learn more about the vision and priorities for Phase 2, hear about the exciting work underway in BC, and connect with the researchers, clinicians, and partners helping move precision oncology forward.
Event venue & nearby stays
Canadian Cancer Society - Vancouver Lodge, 575 West 10th Avenue, Vancouver, Canada